Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Loo

Showing results (141-150 of 177) with videos related to

Pageof 18
Sort By:
Journal of Psychiatry & Neuroscience : JPN|March 1, 1996
Differences in the natural autoantibody patterns of patients with schizophrenia and normal individualsP Lévy-Soussan, A Berneman, M F Poirier, et al.
Angewandte Chemie (International Ed. in English)|December 20, 2002
Multiple emissions from 1,3-diphenyl-5-pyrenyl-2-pyrazoline nanoparticles: evolution from molecular to nanoscale to bulk materialsHongbing Fu, B H Loo, Debao Xiao, et al.
Human Psychopharmacology|January 13, 2004
Double-blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteersM F Poirier, A Galinowski, I Amado, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 8, 2010
Tumour shrinkage and contour change during radiotherapy increase the dose to organs at risk but not the target volumes for head and neck cancer patients treated on the TomoTherapy HiArt™ systemH Loo, J Fairfoul, A Chakrabarti, et al.
The American Journal of Psychiatry|May 1, 1989
Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 productionF Villemain, L Chatenoud, A Galinowski, et al.
Molecular and Cellular Biology|March 1, 1997
Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexesE Manser, H Y Huang, T H Loo, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2000
Evolution of plasma homovanillic acid (HVA) levels during treatment in schizo-affective disorderA Galinowski, C Castelnau, O Spreux-Varoquaux, et al.
Psychopharmacology|January 1, 1983
3H-Rauwolscine binding in platelets from depressed patients and healthy volunteersC Pimoule, M S Briley, C Gay, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|August 1, 1988
[Caffeine and EEG mapping: effects of visuo-spatial task in healthy volunteers]P Etevenon, P Peron-Magnan, S Guillou, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1990
Conjugated catecholamines in human plasma: where are they coming from?J L Cuche, P Brochier, N Klioua, et al.
Pageof 18

Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
Journal of Psychiatry & Neuroscience : JPN|March 1, 1996
Differences in the natural autoantibody patterns of patients with schizophrenia and normal individualsP Lévy-Soussan, A Berneman, M F Poirier, et al.
Angewandte Chemie (International Ed. in English)|December 20, 2002
Multiple emissions from 1,3-diphenyl-5-pyrenyl-2-pyrazoline nanoparticles: evolution from molecular to nanoscale to bulk materialsHongbing Fu, B H Loo, Debao Xiao, et al.
Human Psychopharmacology|January 13, 2004
Double-blind comparative study of the action of repeated administration of milnacipran versus placebo on cognitive functions in healthy volunteersM F Poirier, A Galinowski, I Amado, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 8, 2010
Tumour shrinkage and contour change during radiotherapy increase the dose to organs at risk but not the target volumes for head and neck cancer patients treated on the TomoTherapy HiArt™ systemH Loo, J Fairfoul, A Chakrabarti, et al.
The American Journal of Psychiatry|May 1, 1989
Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 productionF Villemain, L Chatenoud, A Galinowski, et al.
Molecular and Cellular Biology|March 1, 1997
Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexesE Manser, H Y Huang, T H Loo, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 28, 2000
Evolution of plasma homovanillic acid (HVA) levels during treatment in schizo-affective disorderA Galinowski, C Castelnau, O Spreux-Varoquaux, et al.
Psychopharmacology|January 1, 1983
3H-Rauwolscine binding in platelets from depressed patients and healthy volunteersC Pimoule, M S Briley, C Gay, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|August 1, 1988
[Caffeine and EEG mapping: effects of visuo-spatial task in healthy volunteers]P Etevenon, P Peron-Magnan, S Guillou, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1990
Conjugated catecholamines in human plasma: where are they coming from?J L Cuche, P Brochier, N Klioua, et al.
Pageof 18